|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2008-2-27
|
|
pubmed:abstractText |
We tested the hypothesis that plasma levels of plasminogen activator inhibitor-1 (PAI-1) are influenced by percutaneous coronary intervention (PCI) with the implantation of drug eluting stents (DES) and are able to predict the occurrence of in-stent restenosis (ISR).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1538-7836
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
6
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
508-13
|
|
pubmed:meshHeading |
pubmed-meshheading:18182031-Aged,
pubmed-meshheading:18182031-Angiography,
pubmed-meshheading:18182031-Coronary Restenosis,
pubmed-meshheading:18182031-Drug-Eluting Stents,
pubmed-meshheading:18182031-Female,
pubmed-meshheading:18182031-Humans,
pubmed-meshheading:18182031-Male,
pubmed-meshheading:18182031-Middle Aged,
pubmed-meshheading:18182031-Plasminogen Activator Inhibitor 1,
pubmed-meshheading:18182031-Regression Analysis,
pubmed-meshheading:18182031-Risk Factors,
pubmed-meshheading:18182031-Ticlopidine,
pubmed-meshheading:18182031-Time Factors,
pubmed-meshheading:18182031-Tissue Plasminogen Activator,
pubmed-meshheading:18182031-Treatment Outcome
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Plasminogen activator inhibitor-1 predicts coronary in-stent restenosis of drug-eluting stents.
|
|
pubmed:affiliation |
Department of Cardiology, Medical University of Vienna, Vienna, Austria.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
